- $801.14m
- $929.71m
- $139.91m
U.S. STOCKS ON THE MOVE-VerifyMe, Coherus BioSciences, bluebird bio
U.S. STOCKS ON THE MOVE-Carrier Global, Qualcomm, Nikola
Avid Biosciences falls as it cuts FY24 revenue forecast
Avid Bioservices Inc reports results for the quarter ended in October - Earnings Summary
Avid Bioservices Inc expected to post a loss of 6 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Avid Bioservices Partners With California Institute for Regenerative Medicine to Provide CDMO Services for Cell and Gene Therapy Programs
Brief: Avid Bioservices Completes Construction Of New Cell And Gene Therapy Development And Manufacturing Facility
U.S. RESEARCH ROUNDUP- Autozone, Sherwin-Williams, Walmart
Avid Bioservices Inc reports results for the quarter ended in July - Earnings Summary
Avid Bioservices Inc expected to post a loss of 3 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Avid Bioservices sees FY revenue of USD 145-165 million
Avid Bioservices Inc reports results for the quarter ended in April - Earnings Summary
Avid Bioservices falls on forecasting fiscal 2024 revenue below estimates
Brief: Avid Bioservices Reports Financial Results For Fourth Quarter
Avid Bioservices Inc expected to post breakeven results a share - Earnings Preview
Annual Financial Report
Lseg Netherlands: Annual Financial Report